UAB Cardiothoracic Surgery Annual Report 2015-16 UAB Medicine Cardiothoracic Surgery 2015/16 Annual | Page 14
ADULT CARDIAC SURGERY
OUTCOMES
UAB’s TAVR Mortality, August 2012 – 2015
2012 – 2014
2015
TAVR Volumes
202
166
Mortality
6
2
Percent Mortality
3.0%
1.2%
STS/ACC TVT Benchmark
3.3%
UAB’s TAVR mortality for August 2012 through 2015 is lower than the STS/ACC TVT Registry Benchmark.
(Source: STS/ACC TVT Registry 2015 Q2 Outcomes Report – RQ4).
UAB’s valve team has utilized various techniques for implantation of the TAVR valve,
tailored to the needs of the patient.
TRANSFEMORAL
APPROACH
71%
OF CASES
TRANSAPICAL
APPROACH
TRANSAORTIC
APPROACH
12%
OF CASES
17%
OF CASES
92% of transcatheter aortic valve replacements
are implanted transfemorally utilizing the Edwards Sapien 3 transcatheter heart
(aortic) valve. (Image used with permission)
The Medtronic CoreValve Evolut R
is approved for TAVR procedures and for valve-in-valve procedures in the aortic
position. (Image used with permission)
12
Cardiothoracic Surgery Annual Report